SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 62 filers reported holding SPERO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $327 | +30.8% | 272,024 | +56.8% | 0.00% | 0.0% |
| Q2 2023 | $250 | -99.8% | 173,539 | +183.8% | 0.00% | 0.0% |
| Q3 2022 | $121,000 | +72.9% | 61,152 | -35.6% | 0.00% | – |
| Q2 2022 | $70,000 | +180.0% | 94,977 | +4209.3% | 0.00% | – |
| Q2 2019 | $25,000 | -55.4% | 2,204 | -42.6% | 0.00% | – |
| Q2 2018 | $56,000 | – | 3,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,376,968 | $13,247,000 | 23.08% |
| Aquilo Capital Management, LLC | 1,154,356 | $11,099,000 | 4.17% |
| VHCP Management II, LLC | 474,015 | $4,558,000 | 1.20% |
| AWM Investment Company, Inc. | 474,344 | $4,561,000 | 0.89% |
| Alphabet Inc. | 1,112,473 | $10,696,000 | 0.65% |
| BVF INC/IL | 845,405 | $8,129,000 | 0.62% |
| Novo Holdings A/S | 931,099 | $8,948,000 | 0.58% |
| Artal Group S.A. | 500,000 | $4,808,000 | 0.19% |
| Rock Springs Capital Management LP | 525,000 | $5,048,000 | 0.16% |
| Granahan Investment Management | 148,867 | $1,431,000 | 0.07% |